Autism Spectrum Disorder Treatment Market Size, Share & COVID-19 Impact Analysis, By Treatment Type (Communication & Behavioral Therapies {Applied Behavior Analysis (ABA), Speech & Language Therapy, Occupational Therapy, and Others}, Drug Therapies {Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others}), By Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108573

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 8.5% from 2023 to 2030
Unit	Value (USD billion)
Segmentation	By Treatment Type By Communication & Behavioral Therapies Applied Behavior Analysis (ABA) Speech & Language Therapy Occupational Therapy Others By Drug Therapies Antipsychotic Drugs SSRIs/Antidepressants Stimulants Sleep Medications Others
	By Type Autistic Disorder Asperger Syndrome Pervasive Developmental Disorder (PDD) Others
	By Geography North America (By Treatment Type, Type, and Country) U.S. Canada Europe (By Treatment Type, Type, and Country/Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Treatment Type, Type, and Country/Sub-Region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Treatment Type, Type, and Country/Sub-Region) Brazil Mexico Rest of Latin America The Middle East & Africa (By Treatment Type, Type, and Country/Sub-Region) GCC Countries South Africa Rest of the Middle East & Africa